Medical information Clinical review pending

Genetic Testing

Jak 2 Mutation Detection Panel Exons 12

Genetic test to identify mutations in the Jak2 gene, associated with blood disorders like polycythemia vera and essential thrombocythemia. Helps in early diagnosis and management.

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question

Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample: Bone Marrow or Peripheral Blood (EDTA Vacutainer tube, 2ml). Confirm specific requirements with the laboratory before collection.
Results: Approximately 7-8 days. Confirm exact turnaround time with the laboratory before booking.
Preparation: No specific patient preparation is required. However, the test is typically ordered by a physician. Confirm with the laboratory before booking.

Test priceKSh 18,000

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the Jak 2 Mutation Detection Panel Exons 12 test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

Insurer or scheme name & policy / member number
A clinician's request / prescription for the test
Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

Full name *

Mobile number *

+254

Insurer or scheme

Policy / member number (optional)

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

WhatsApp the claims team Call us

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

✓Suspected myeloproliferative neoplasm (MPN)
✓Diagnosis of polycythemia vera
✓Diagnosis of essential thrombocythemia
✓Diagnosis of primary myelofibrosis
✓Unexplained elevated blood cell counts
✓Family history of MPNs

In plain language

What this test helps you understand

This test helps identify mutations in the Jak2 gene, which are associated with certain blood disorders (myeloproliferative neoplasms). It aids in diagnosis, prognosis, and guiding treatment strategies for conditions like polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

The Jak 2 Mutation Detection Panel Exons 12 is a genetic test used to identify specific mutations in the Jak2 gene. These mutations are often linked to myeloproliferative neoplasms (MPNs), a group of blood disorders. This test is important for diagnosing conditions such as polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Understanding the presence of these mutations can guide treatment decisions and improve patient care. This test focuses specifically on Exon 12 of the Jak2 gene. Discuss the need for this test with your doctor.

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

Speak with us

We check the test and answer your questions before collection.

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

Understand your report

A counselor helps you understand the result and the next steps.

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →

PreparationNo specific patient preparation is required. However, the test is typically ordered by a physician. Confirm with the laboratory before booking.

SampleBone Marrow or Peripheral Blood (EDTA Vacutainer tube, 2ml). Confirm specific requirements with the laboratory before collection.

MethodologyMolecular genetic testing (e.g., PCR, sequencing) to detect mutations in the Jak2 gene Exon 12. Confirm methodology with the laboratory before booking.

PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.

This test detects specific mutations in Jak2 Exon 12. It does not detect mutations in other genes or other exons of the Jak2 gene. A negative result does not completely rule out an MPN. Confirm limitations with the laboratory before booking.

Read your report

What common result terms mean

TermPlain-language meaning

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.

NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.

VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.

Questions people ask

Frequently asked questions

This is a genetic test that looks for specific changes (mutations) in the Jak2 gene, particularly in Exon 12. These mutations are linked to certain blood disorders.

It helps diagnose conditions like polycythemia vera, essential thrombocythemia, and primary myelofibrosis, which are types of blood cancers. It can also help guide treatment decisions.

The test can be performed on a bone marrow sample or a peripheral blood sample collected in a specific type of tube (EDTA Vacutainer).

Results are typically available within 7-8 days, but this can vary. Please confirm the current turnaround time with the laboratory.

Generally, yes. This test is usually ordered by a healthcare provider based on your medical condition. Confirm requirements with the laboratory.

A positive result indicates the presence of a specific mutation in the Jak2 gene. Your doctor will interpret this result in the context of your overall health and discuss the implications and next steps with you.

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

ACMG/AMP technical standards for sequence variant interpretation
ClinGen curation and gene–disease validity frameworks where applicable
LOINC-coded reporting for interoperable results
ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

Last updated: September 27, 2026
Medical review: not yet completed
Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →

Chat on WhatsApp